Int6 reduction activates stromal fibroblasts to enhance transforming activity in breast epithelial cells
Jinfeng Suo(The University of Texas MD Anderson Cancer Center), Eric C. Chang(Baylor College of Medicine), Sabrina Herrera(Mayo Clinic), Alejandro Contreras(Baylor College of Medicine), Daniel Medina(Baylor College of Medicine), Rachel Schiff(Baylor College of Medicine), Samir Hanash(The University of Texas MD Anderson Cancer Center), Carolina Gutiérrez(Baylor College of Medicine), Susan G. Hilsenbeck(Baylor College of Medicine), Xiang H.-F. Zhang(Baylor College of Medicine), Arzu Umar(Erasmus MC), John A. Foekens(National Cancer Centre Japan), Lei Jin(Shenzhen University Health Science Center), Gary C. Chamness(Baylor College of Medicine)
Cited by 12
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k